TOPIC CENTER

41 Articles

Updated Oct 5, 2026

M&A

Latest reporting, analysis, interviews and insight from The Pharma Navigator editorial team.

M&A
Thermo Fisher Anticipates CDMO Growth Amid Industry Shifts
4 min read • 2 years ago
M&A
National Resilience Confirms Layoffs Amid Expansion and Leadership Change
4 min read • 2 years ago
M&A
Lonza Drops CHI Business to Focus on CDMO Services
4 min read • 2 years ago
M&A
KPMG Life Sciences CEO Outlook Report
4 min read • 2 years ago
M&A
Novo Nordisk to Halt Human Insulin Pen Production
4 min read • 2 years ago
M&A
Thermo Fisher Restructures Viral Vector Operations with 160 Layoffs
4 min read • 2 years ago
M&A
ROVI Retains CDMO Business – Rejecting 5 Offers for Sale
4 min read • 2 years ago
M&A
Activist Investors Eyeing Big Pharma: What It Means for the Industry
4 min read • 2 years ago
M&A
AGC Pauses CGT Operations
4 min read • 2 years ago
M&A
Celltrion to Establish Wholly-Owned CDMO Subsidiary by End of 2024
4 min read • 2 years ago
M&A
Evonik Announces 260 More Layoffs as Part of Multi-Year Restructuring
4 min read • 2 years ago
M&A
Tanvex BioPharma and Bora Pharmaceuticals Forge Global Biologics Manufacturing Alliance
4 min read • 2 years ago

‹
1
2
3
4
›

Stay Ahead in Pharma Intelligence

Join industry executives receiving our market briefings.